<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>HEMOFIL M- antihemophilic factor human 
			 </strong><br>Baxter Healthcare Corporation<br></p></div>
<h1><span class="Bold">HEMOFIL M Antihemophilic Factor (Human), Method M, Monoclonal
            Purified Nanofiltered</span></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="ID_c58cc198-fd7c-4c93-9d05-94765ce6de6b"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">HEMOFIL M, Antihemophilic Factor (Human) (AHF), Method M,
                            Monoclonal Purified, is a sterile, nonpyrogenic, dried preparation of
                            antihemophilic factor (Factor VIII, Factor VIII:C, AHF) in concentrated
                            form with a specific activity range of 2 to 22 AHF International
                            Units/mg of total protein. HEMOFIL M contains a maximum of 12.5 mg/mL
                            Albumin, and per AHF International Unit, 0.07 mg polyethylene glycol
                            (3350), 0.39 mg histidine as stabilizing agents, not more than 0.1 mg
                            glycine, 0.1 ng mouse protein, 18 ng organic solvent (tri-n-butyl
                            phosphate) and 50 ng detergent (octoxynol 9). In the absence of the
                            added Albumin (Human), the specific activity is approximately 2,000 AHF
                            International Units/mg of protein. [see <span class="Italics">Clinical Pharmacology</span>]</p>
<p>HEMOFIL M is
                            prepared by the Method M process from pooled human plasma by
                            immunoaffinity chromatography utilizing a murine monoclonal antibody to
                            Factor VIII:C, followed by an ion exchange chromatography step for
                            further purification. Source material may be provided by other US
                            licensed manufacturers. HEMOFIL M also includes an organic solvent
                            (tri-n-butyl phosphate) and detergent (octoxynol 9) virus inactivation
                            step designed to reduce the risk of transmission of <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span> and other
                            viral diseases. The process further includes a nanofiltration step
                            between immunoaffinity chromatography and ion-exchange chromatography as
                            an additional viral clearance step to further improve the viral safety
                            margin of the final product.</p>
<p>Use of an organic
                            solvent (tri-n-butyl phosphate; TNBP) in the manufacture of
                            Antihemophilic Factor (Human) has little or no effect on AHF activity,
                            while lipid enveloped viruses, such as <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span> B and human
                            <span class="product-label-link" type="condition" conceptid="433740" conceptname="Immunodeficiency disorder">immunodeficiency</span> virus (HIV) would be inactivated.<span class="Sup">1</span> The
                            nanofiltration step integrated into the manufacture of AHF-M further
                            enhances the safety margin with respect to adventitious
                            viruses.</p>
<p>Each bottle of HEMOFIL M is labeled with
                            the AHF activity expressed in International Units (IU) per bottle.
                            This potency assignment is referenced to the World Health Organization
                            International Standard.</p>
<p>The purity of HEMOFIL M
                            has been thought to influence the difficulty of producing an accurate
                            potency measurement. Experiments have shown that to achieve accurate
                            activity levels, such a potency assay should be conducted using plastic
                            test tubes and pipets as well as substrate containing normal levels of
                            von Willebrand's Factor.</p>
<p><span class="Italics">In vitro</span> studies demonstrate that the
                            HEMOFIL M manufacturing process provides for viral reduction. These
                            reductions are achieved through a combination of process chemistry,
                            partitioning and/or inactivation during solvent/detergent treatment, and
                            immunoaffinity chromatography. Introduction of a nanofiltration step
                            with the 0.1µm prefilter and the ASAHI Planova 20N nanofilter provides a
                            virus removal capacity for human <span class="product-label-link" type="condition" conceptid="433740" conceptname="Immunodeficiency disorder">immunodeficiency</span> virus, Type 1 (HIV-1),
                            <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span> A virus (HAV), bovine viral <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> virus (BVDV),
                            pseudorabies virus (PRV), mice minute virus (MMV), and human parvovirus
                            B19 (B19V) in the order of four (4) logs or higher. B19V removal data
                            were obtained with a <span class="product-label-link" type="condition" conceptid="4120014" conceptname="Polymerase chain reaction">Polymerase Chain Reaction</span> (PCR) assay not
                            correlated to an infectivity assay.</p>
<p>Studies for
                            nanofiltration and other process steps, summarized in Table 1,
                            demonstrate virus clearance during the HEMOFIL M manufacturing process
                            using HIV-1; BVDV, a generic model for lipid enveloped RNA viruses, such
                            as <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span> C virus (HCV); PRV, a model for lipid enveloped DNA
                            viruses, such as <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span> B virus (HBV); canine parvovirus (CPV), a
                            model for non-lipid enveloped DNA viruses, such as B19V, HAV, and MMV.
                            </p>
<table width="100%">
<caption><span>Table 1 In Vitro Virus Clearance During the Manufacture of
                                HEMOFIL M </span></caption>
<col width="22%">
<col width="15%">
<col width="12%">
<col width="13%">
<col width="12%">
<col width="11%">
<col width="10%">
<tfoot><tr><td colspan="7" align="left"><dl class="Footnote">
<dt><a name="footnote-1" href="#footnote-reference-1">*</a></dt>
<dd>As
                                                Solvent/Detergent treatment does not inactivate
                                                non-lipid enveloped
                                        viruses.</dd>
<dt><a name="footnote-2" href="#footnote-reference-2">†</a></dt>
<dd>Not
                                                Applicable for lipid enveloped viruses due to the
                                                presence of (virucidal) solvent/detergent reagents
                                                in the starting
                                        material.</dd>
</dl></td></tr></tfoot>
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Toprule" align="center" rowspan="3"><p class="First"><span class="Bold">Process Step
                                            Evaluated</span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" colspan="6"><p class="First"><span class="Bold">Virus Clearance, log
                                                <span class="Sub">10</span></span></p></td>
</tr>
<tr>
<td class="Botrule Lrule" align="center" colspan="3"><p class="First"><span class="Bold">Lipid-enveloped</span></p></td>
<td class="Botrule Lrule Rrule" align="center" colspan="3"><p class="First"><span class="Bold">Non-Lipid
                                                enveloped</span></p></td>
</tr>
<tr>
<td class="Botrule Lrule" align="center"><p class="First"><span class="Bold">HIV-1</span></p></td>
<td class="Botrule Lrule" align="center"><p class="First"><span class="Bold">BVDV</span></p></td>
<td class="Botrule Lrule" align="center"><p class="First"><span class="Bold">PRV</span></p></td>
<td class="Botrule Lrule" align="center"><p class="First"><span class="Bold">HAV
                                            </span></p></td>
<td class="Botrule Lrule" align="center"><p class="First"><span class="Bold">CPV</span></p></td>
<td class="Botrule Lrule Rrule" align="center"><p class="First"><span class="Bold">MMV</span></p></td>
</tr>
<tr>
<td class="Botrule Lrule" align="center"><p class="First">Solvent/Detergent Treatment</p></td>
<td class="Botrule Lrule" align="center"><p class="First">&gt;4.8</p></td>
<td class="Botrule Lrule" align="center"><p class="First">&gt;6.8</p></td>
<td class="Botrule Lrule" align="center"><p class="First">&gt;6.9</p></td>
<td class="Botrule Lrule" align="center"><p class="First">NT<a name="footnote-reference-1" href="#footnote-1" class="Sup">*</a></p></td>
<td class="Botrule Lrule" align="center"><p class="First">NT<a href="#footnote-1" class="Sup">*</a></p></td>
<td class="Botrule Lrule Rrule" align="center"><p class="First">NT<a href="#footnote-1" class="Sup">*</a></p></td>
</tr>
<tr>
<td class="Botrule Lrule" align="center"><p class="First">Immunoaffinity
                                        Chromatography</p></td>
<td class="Botrule Lrule" align="center"><p class="First">N.A.<a name="footnote-reference-2" href="#footnote-2" class="Sup">†</a></p></td>
<td class="Botrule Lrule" align="center"><p class="First">N.A.<a href="#footnote-2" class="Sup">†</a></p></td>
<td class="Botrule Lrule" align="center"><p class="First">N.A.<a href="#footnote-2" class="Sup">†</a></p></td>
<td class="Botrule Lrule" align="center"><p class="First">≥4.5</p></td>
<td class="Botrule Lrule" align="center"><p class="First">≥3.9</p></td>
<td class="Botrule Lrule Rrule" align="center"><p class="First">NT</p></td>
</tr>
<tr>
<td class="Botrule Lrule" align="center"><p class="First">Nanofiltration</p></td>
<td class="Botrule Lrule" align="center"><p class="First">&gt;5.5</p></td>
<td class="Botrule Lrule" align="center"><p class="First">&gt;4.6</p></td>
<td class="Botrule Lrule" align="center"><p class="First">&gt;4.4</p></td>
<td class="Botrule Lrule" align="center"><p class="First">&gt;5.4</p></td>
<td class="Botrule Lrule" align="center"><p class="First">NT</p></td>
<td class="Botrule Lrule Rrule" align="center"><p class="First">&gt;5.0</p></td>
</tr>
<tr class="Last">
<td class="Botrule Lrule" align="center"><p class="First"><span class="Bold">Cumulative
                                                Total, log<span class="Sub">10</span></span></p></td>
<td class="Botrule Lrule" align="center"><p class="First">&gt;10.3</p></td>
<td class="Botrule Lrule" align="center"><p class="First">&gt;11.4</p></td>
<td class="Botrule Lrule" align="center"><p class="First">&gt;11.3</p></td>
<td class="Botrule Lrule" align="center"><p class="First">&gt;9.9</p></td>
<td class="Botrule Lrule" align="center"><p class="First">≥3.9
                                        </p></td>
<td class="Botrule Lrule Rrule" align="center"><p class="First">&gt;5.0</p></td>
</tr>
</tbody>
</table>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="ID_2bcb2662-964d-4101-bfc0-c8bf8c6cb8c4"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Antihemophilic factor (AHF) is a protein found in normal plasma
                            which is necessary for clot formation. </p>
<p>The
                            administration of HEMOFIL M provides an increase in plasma levels of AHF
                            and can temporarily correct the coagulation defect of patients with
                            <span class="product-label-link" type="condition" conceptid="434007" conceptname="Hereditary factor VIII deficiency disease">hemophilia A</span> (classical <span class="product-label-link" type="condition" conceptid="4236898" conceptname="Hemophilia">hemophilia</span>). </p>
<p>The
                            half-life of HEMOFIL M administered to Factor VIII deficient patients
                            has been shown to be 14.8 ± 3.0 hours.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="ID_83803aef-9a8f-4e8d-a3b3-e3d767f7bb46"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">HEMOFIL M is indicated in <span class="product-label-link" type="condition" conceptid="434007" conceptname="Hereditary factor VIII deficiency disease">hemophilia A</span> (classical <span class="product-label-link" type="condition" conceptid="4236898" conceptname="Hemophilia">hemophilia</span>)
                            for the prevention and control of hemorrhagic
                            episodes.</p>
<p>HEMOFIL M is not indicated in von
                            Willebrand's disease.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="ID_53e9381a-ece7-4023-bfe4-17e24ce345b8"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">HEMOFIL M is contraindicated in patients with a known
                            <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to the active substance, to excipients, or to mouse
                            proteins.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="ID_aa74c973-6ef9-43b8-8f7d-bb88c70e9ade"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<div class="Section" data-sectionCode="34071-1">
<a name="ID_4f90d2f4-d7bb-4a77-8b39-1cac2e01aac1"></a><a name="section-5.1"></a><p></p>
<h2><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span></h2>
<p class="First">Allergic-type <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reactions</span>, including
                                    <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span>, have been reported with HEMOFIL M and have been
                                    manifested by <span class="product-label-link" type="condition" conceptid="256717" conceptname="Bronchospasm">bronchospasm</span>, <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="77670" conceptname="Chest pain">chest pain</span>,
                                    facial <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, and
                                    <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="ID_c2163599-f328-4a2c-a42f-620d4c83986a"></a><a name="section-5.2"></a><p></p>
<h2>Neutralizing Antibodies</h2>
<p class="First">The development of neutralizing antibodies (inhibitors)
                                    to Factor VIII is a known complication of the treatment of
                                    patients with <span class="product-label-link" type="condition" conceptid="434007" conceptname="Hereditary factor VIII deficiency disease">Hemophilia A</span>. Inhibitors have predominantly been
                                    reported in previously untreated patients. The risk of
                                    developing inhibitors is correlated to the extent of exposure to
                                    Factor VIII, the risk being highest within the first 20 exposure
                                    days, and to other genetic and environmental factors. The risk
                                    for inhibitor development depends on a number of factors
                                    relating to the characteristics of the patient (e.g., type of
                                    the Factor VIII gene mutation, family history, ethnicity), which
                                    are believed to represent the most significant risk factors for
                                    inhibitor formation.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="ID_4d08ac13-f567-4f9a-8d20-f5598ad01ed3"></a><a name="section-5.3"></a><p></p>
<h2>Transmission of Infectious Agents</h2>
<p class="First">Because HEMOFIL M is made from human blood, it may
                                    carry a risk of transmitting infectious agents, e.g., viruses,
                                    the variant Creutzfeldt-Jakob disease (vCJD) agent and,
                                    theoretically, the Creutzfeldt-Jakob disease (CJD) agent. This
                                    also applies to unknown or emerging viruses and other
                                    pathogens.</p>
<p>All <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> thought by a
                                    physician possibly to have been transmitted by this product
                                    should be reported by the physician or other healthcare provider
                                    to Baxter Healthcare Corporation at <br>1-800-423-2862 (in the
                                    U.S.) or FDA at 1-800-FDA-1088 or <span class="Italics">www.fda.gov/medwatch</span>. The physician should
                                    discuss the risks and benefits of this product with the
                                    patient.</p>
<p>Individuals who receive infusions
                                    of blood or plasma products may develop signs and/or symptoms of
                                    some <span class="product-label-link" type="condition" conceptid="440029" conceptname="Viral disease">viral infections</span>, particularly non-A, non-B <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span>. As
                                    indicated under <span class="Italics">Clinical
                                        Pharmacology</span>, however, a group of such patients
                                    treated with HEMOFIL M did not demonstrate signs or symptoms of
                                    non-A, non-B <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span> over observation periods ranging from
                                    three to nine months.</p>
</div>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="ID_00a0e92f-30a9-4271-9611-1839a2b060bd"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First">Identification of the clotting defect as a Factor VIII
                            deficiency is essential before the administration of HEMOFIL M is
                            initiated.</p>
<div class="Section" data-sectionCode="42232-9">
<a name="ID_989d1cd2-a387-4399-b8df-8fbb3b271aef"></a><a name="section-6.1"></a><p></p>
<h2>Factor VIII Inhibitors</h2>
<p class="First">Evaluate patients for the development of Factor VIII
                                    inhibitors if the expected plasma Factor VIII activity levels
                                    are not attained or if <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> is not controlled with an
                                    appropriate dose.</p>
<p>No benefit may be
                                    expected from this product in treating other
                                    deficiencies.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_e6239cbe-6023-4d1d-aac6-d9452c026210"></a><a name="section-6.2"></a><p></p>
<h2>Formation of Antibodies to Mouse Protein</h2>
<p class="First">HEMOFIL M contains trace amounts of mouse protein (less
                                    than 0.1 ng/AHF activity units). The possibility exists that
                                    patients treated with HEMOFIL M may develop <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to
                                    the mouse proteins. There have been no cases of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>
                                    to the mouse proteins reported. </p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="ID_d8c4393f-868d-4cf6-8184-3274223a64f8"></a><a name="section-6.3"></a><p></p>
<h2>Increase in Pulse Rate</h2>
<p class="First">Determine the pulse rate before and during
                                    administration of HEMOFIL M. Should a significant increase
                                    occur, reduce the rate of administration or temporarily halt the
                                    injection to allow the symptoms to disappear
                                    promptly.</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="ID_6ad78671-0307-431f-913a-47f62b8d5921"></a><a name="section-6.4"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">Perform appropriate laboratory tests on the patient's
                                    plasma at suitable intervals to ensure that adequate AHF levels
                                    have been reached and are maintained.</p>
<p>If
                                    the AHF content of the patient's plasma fails to reach expected
                                    levels or if <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> is not controlled after apparently
                                    adequate dosage, the presence of inhibitor should be suspected.
                                    By appropriate laboratory procedures, the presence of inhibitor
                                    can be demonstrated and quantified in terms of AHF units
                                    neutralized by each mL of plasma or by the total estimated
                                    plasma volume. </p>
<p>If the inhibitor is at low
                                    levels (i.e., &lt;10 Bethesda units per mL), after
                                    administration of sufficient AHF units to neutralize the
                                    inhibitor, additional AHF units will elicit the predicted
                                    response.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="ID_43ffa33c-d395-41f9-b8cc-bfff6fa25c8d"></a><a name="section-6.5"></a><p></p>
<h2>Pregnancy</h2>
<p class="First"><span class="Bold">Pregnancy Category
                                        C</span></p>
<p>Animal reproduction
                                    studies have not been conducted with HEMOFIL M. The safety of
                                    HEMOFIL M for use in pregnant women has not been established. It
                                    is not known whether HEMOFIL M can cause fetal harm when
                                    administered to a pregnant woman or can affect reproduction
                                    capacity. HEMOFIL M should be given to a pregnant woman only if
                                    clearly needed.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="ID_ce2126da-53e1-4f49-bf49-1506f6135fbd"></a><a name="section-6.6"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">The safety of HEMOFIL M for use in nursing mothers has
                                    not been established. It is not known whether this drug is
                                    excreted into human milk. Physicians should carefully consider
                                    the potential risks and benefits for each specific patient
                                    before prescribing HEMOFIL M. HEMOFIL M should be given to
                                    nursing mothers only if clinically indicated.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="ID_bfc78da0-0ff5-481a-9f40-2f6764960c9a"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<div class="Section" data-sectionCode="34084-4">
<a name="ID_07a2f4e1-ba12-455d-82e6-79297c19a73f"></a><a name="section-7.1"></a><p></p>
<h2>Adverse Reactions from Clinical Trials</h2>
<p class="First">The adverse reactions presented in this section have
                                    been identified based on clinical trial experience with HEMOFIL
                                    M in patients previously treated with other Factor VIII
                                    concentrates or blood products (N = 74), and previously
                                    untreated patients (PUPs; N = 50).</p>
<table width="100%">
<col width="38%">
<col width="36%">
<col width="26%">
<tfoot><tr><td colspan="3" align="left"><dl class="Footnote">
<dt><a name="footnote-3" href="#footnote-reference-3">*</a></dt>
<dd>In a
                                                  study that included 43 evaluable PUPs and 10
                                                  minimally treated patients (MTPs), i.e., patients
                                                  with a single exposure to other Factor VIII
                                                  concentrates or blood products, 3 of the total of
                                                  53 patients (5.7%) developed an inhibitor while on
                                                  study.</dd>
</dl></td></tr></tfoot>
<tbody class="Headless">
<tr class="First"><td class="Botrule Lrule Rrule Toprule" align="center" colspan="3"><p class="First"><span class="Bold">Clinical
                                                  Trial Adverse Reactions</span></p></td></tr>
<tr>
<td class="Botrule Lrule" align="center"><p class="First"><span class="Bold">System Organ
                                                  Class (SOC)</span></p></td>
<td class="Botrule Lrule" align="center"><p class="First"><span class="Bold">Preferred
                                                  MedDRA Term</span></p></td>
<td class="Botrule Lrule Rrule" align="center">
<p class="First"><span class="Bold">Number of
                                                  Cases</span></p>
<p><span class="Bold">(Frequency</span></p>
<p><span class="Bold">Percentage)</span></p>
</td>
</tr>
<tr>
<td class="Botrule Lrule">
<p class="First"><span class="Bold">BLOOD AND
                                                  LYMPHATIC</span></p>
<p><span class="Bold">SYSTEM
                                                  DISORDERS</span></p>
</td>
<td class="Botrule Lrule"><p class="First">Factor VIII
                                                  inhibition</p></td>
<td class="Botrule Lrule Rrule" align="center"><p class="First">3 (5.7%)<a name="footnote-reference-3" href="#footnote-3" class="Sup">*</a></p></td>
</tr>
<tr>
<td class="Botrule Lrule" rowspan="3"><p class="First"><span class="Bold">NERVOUSSYSTEM
                                                DISORDERS</span></p></td>
<td class="Botrule Lrule"><p class="First"><span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">Dizziness</span></p></td>
<td class="Botrule Lrule Rrule" align="center"><p class="First">1 (0.8%)</p></td>
</tr>
<tr>
<td class="Botrule Lrule"><p class="First"><span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span></p></td>
<td class="Botrule Lrule Rrule" align="center"><p class="First">1 (0.8%)</p></td>
</tr>
<tr>
<td class="Botrule Lrule"><p class="First"><span class="product-label-link" type="condition" conceptid="436235" conceptname="Taste sense altered">Dysgeusia</span></p></td>
<td class="Botrule Lrule Rrule" align="center"><p class="First">1 (0.8%)</p></td>
</tr>
<tr>
<td class="Botrule Lrule" rowspan="2"><p class="First"><span class="Bold">GENERAL
                                                  DISORDERS AND ADMINISTRATION SITE
                                                  CONDITIONS</span></p></td>
<td class="Botrule Lrule"><p class="First"><span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">Pyrexia</span></p></td>
<td class="Botrule Lrule Rrule" align="center"><p class="First">1 (0.8%)</p></td>
</tr>
<tr class="Last">
<td class="Botrule Lrule"><p class="First">Infusion site
                                                  <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">inflammation</span></p></td>
<td class="Botrule Lrule Rrule" align="center"><p class="First">2 (1.6%)</p></td>
</tr>
</tbody>
</table>
<p>HEMOFIL M was administered to 11 patients
                                    previously untreated with Antihemophilic Factor (Human). They
                                    have shown no signs of <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span> or <span class="product-label-link" type="condition" conceptid="439727" conceptname="Human immunodeficiency virus infection">HIV infection</span> following
                                    three to nine months of evaluation.</p>
<p>A
                                    study of 25 patients treated with HEMOFIL M and monitored for
                                    three to six months has demonstrated no evidence of antibody
                                    response to mouse protein. More than 1,000 infusions of HEMOFIL
                                    M have been administered during the clinical trials. Reported
                                    events included a single episode each of <span class="product-label-link" type="condition" conceptid="4034235" conceptname="Tight chest">chest tightness</span>,
                                    fuzziness and <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, and one patient reported an unusual
                                    taste after each infusion.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="ID_8eef6908-1d1d-4310-a7ef-657308281ec3"></a><a name="section-7.2"></a><p></p>
<h2>Post-marketing Adverse Reactions</h2>
<p class="First">In addition to clinical trials, the following adverse
                                    reactions have been reported in the post-marketing experience,
                                    listed by MedDRA System Organ Class (SOC), then by Preferred
                                    Term.</p>
<p><span class="Underline"><span class="product-label-link" type="condition" conceptid="440371" conceptname="Disorder of immune function">Immune System Disorders</span>:</span> <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reaction</span>,
                                    <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> </p>
<p><span class="Underline"><span class="product-label-link" type="condition" conceptid="375252" conceptname="Disorder of eye">Eye Disorders</span>:</span> visual
                                    impairment, <span class="product-label-link" type="condition" conceptid="442546" conceptname="Red eye">ocular hyperemia</span></p>
<p><span class="Underline"><span class="product-label-link" type="condition" conceptid="321588" conceptname="Heart disease">Cardiac Disorders</span>:</span> <span class="product-label-link" type="condition" conceptid="438555" conceptname="Cyanosis">cyanosis</span>,
                                    <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span>, <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span></p>
<p><span class="Underline"><span class="product-label-link" type="condition" conceptid="443784" conceptname="Vascular disorder">Vascular Disorders</span>:</span>
                                    <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span></p>
<p><span class="Underline">Respiratory, Thoracic, and Mediastinal
                                        Disorders</span>: <span class="product-label-link" type="condition" conceptid="256717" conceptname="Bronchospasm">bronchospasm</span>, <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span>, <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">cough</span>,
                                    <span class="product-label-link" type="condition" conceptid="316814" conceptname="Hyperventilation">hyperventilation</span></p>
<p><span class="Underline"><span class="product-label-link" type="condition" conceptid="4302537" conceptname="Digestive system finding">Gastrointestinal Disorders</span>:</span>
                                    <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, abdominal
                                        <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span></p>
<p><span class="Underline">Skin and Subcutaneous Tissue Disorders:</span>
                                    <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>,
                                        <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">hyperhidrosis</span></p>
<p><span class="Underline">Musculoskeletal and Connective Tissue
                                        Disorders:</span> musculoskeletal
                                        <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span></p>
<p><span class="Underline">General Disorders and Administration Site
                                        Conditions:</span> facial <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, <span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">chills</span>, <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">fatigue</span>,
                                    <span class="product-label-link" type="condition" conceptid="77670" conceptname="Chest pain">chest pain</span>, <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span></p>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="ID_49086942-7533-447e-a57f-64c2204173bd"></a><a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">For intravenous use only.</p>
<p>The expected
                                <span class="Italics">in vivo</span> peak AHF level,
                            expressed as IU/dL of plasma or % (percent) of normal, can be calculated
                            by multiplying the dose administered per kg body weight (IU/kg) by two.
                            This calculation is based on the clinical finding by Abildgaard,
                                <span class="Italics">et al</span>,<span class="Sup">2</span> which is
                            supported by data from the collaborative study of <span class="Italics">in vivo</span> recovery and survival with 15
                            different lots of HEMOFIL M on 56 hemophiliacs that demonstrated a mean
                            peak recovery point above the mean pre-infusion baseline of about 2.0
                            IU/dL per infused IU/kg body
                            weight.<span class="Sup">3</span></p>
<p>Examples:</p>
<p>(1)
                            A dose of 1750 IU AHF administered to a 70 kg patient, i.e., 25 IU/kg
                            (1750/70), should be expected to cause a peak post-infusion AHF increase
                            of 25 x 2 = 50 IU/dL (50% of normal).</p>
<p>(2) A peak
                            level of 70% is required in a 40 kg child. In this situation the dose
                            would be 70/2 x 40 = 1400 IU.</p>
<p><span class="Bold">Recommended Dosage Schedule
                            </span></p>
<p>Physician supervision of the dosage is
                            required. The following dosage schedule may be used as a
                            guide.</p>
<table width="100%">
<col width="34%">
<col width="32%">
<col width="34%">
<tbody class="Headless">
<tr class="First"><td class="Botrule Lrule Toprule" colspan="3"><p class="First"><span class="Bold"><span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">HEMORRHAGE</span></span></p></td></tr>
<tr>
<td class="Botrule Lrule" align="center"><p class="First"><span class="Bold">Degree of
                                                <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">hemorrhage</span></span>   </p></td>
<td class="Botrule Lrule" align="center"><p class="First"><span class="Bold">Required peak
                                                post-infusion AHF activity in the blood (as % of
                                                normal or IU/dL plasma)</span></p></td>
<td class="Botrule Lrule" align="center"><p class="First"><span class="Bold">Frequency of
                                                infusion</span></p></td>
</tr>
<tr>
<td class="Botrule Lrule"><p class="First"> Early <span class="product-label-link" type="condition" conceptid="76784" conceptname="Hemarthrosis">hemarthrosis</span> or
                                            muscle bleed or oral bleed </p></td>
<td class="Botrule Lrule" align="center"><p class="First"> 20-40
                                        </p></td>
<td class="Botrule Lrule"><p class="First"> Begin infusion every
                                            12 to 24 hours for one-three days until the <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span>
                                            episode as indicated by <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> is resolved or healing is
                                            achieved. </p></td>
</tr>
<tr>
<td class="Botrule Lrule"><p class="First"> More extensive
                                            <span class="product-label-link" type="condition" conceptid="76784" conceptname="Hemarthrosis">hemarthrosis</span>, muscle bleed, or <span class="product-label-link" type="condition" conceptid="4147001" conceptname="Hematoma">hematoma</span>
                                        </p></td>
<td class="Botrule Lrule" align="center"><p class="First"> 30-60
                                        </p></td>
<td class="Botrule Lrule"><p class="First"> Repeat infusion every
                                            12 to 24 hours for usually three days or more until <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>
                                            and <span class="product-label-link" type="condition" conceptid="4052648" conceptname="Disability">disability</span> are resolved.   </p></td>
</tr>
<tr>
<td class="Botrule Lrule"><p class="First"> Life threatening
                                            bleeds such as <span class="product-label-link" type="condition" conceptid="375415" conceptname="Injury of head">head injury</span>, throat bleed, severe
                                            <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span>   </p></td>
<td class="Botrule Lrule" align="center"><p class="First"> 60-100
                                        </p></td>
<td class="Botrule Lrule"><p class="First"> Repeat infusion every
                                            8 to 24 hours until threat is resolved.
                                        </p></td>
</tr>
<tr><td class="Botrule Lrule" colspan="3"><p class="First"><span class="Bold">SURGERY</span>  
                                        </p></td></tr>
<tr>
<td class="Botrule Lrule"><p class="First"><span class="Bold">Type of operation
                                             </span></p></td>
<td class="Botrule Lrule" align="center"><p class="First">  
                                        </p></td>
<td class="Botrule Lrule"><p class="First">   </p></td>
</tr>
<tr>
<td class="Botrule Lrule"><p class="First"> Minor surgery,
                                            including tooth extraction </p></td>
<td class="Botrule Lrule" align="center"><p class="First"> 60-80
                                        </p></td>
<td class="Botrule Lrule"><p class="First"> A single infusion
                                            plus oral antifibrinolytic therapy within one hour is
                                            sufficient in approximately 70% of cases.  
                                        </p></td>
</tr>
<tr class="Last">
<td class="Botrule Lrule"><p class="First"> Major surgery
                                        </p></td>
<td class="Botrule Lrule" align="center"><p class="First"> 80-100
                                            (pre- and post-operative) </p></td>
<td class="Botrule Lrule"><p class="First"> Repeat infusion every
                                            8 to 24 hours depending on state of healing.  
                                        </p></td>
</tr>
</tbody>
</table>
<p>If <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> is not controlled with the prescribed dose,
                            determine the plasma level of Factor VIII and administer a sufficient
                            dose of HEMOFIL M to achieve a satisfactory clinical
                            response.</p>
<p>Under certain circumstances (e.g.,
                            presence of a low titer inhibitor) doses larger than those recommended
                            may be necessary as per standard care. In patients with high titer
                            Factor VIII inhibitors, HEMOFIL M therapy may not be effective and other
                            therapeutic options should be considered.</p>
<p>The
                            dosage and duration of treatment depend on the severity of Factor VIII
                            deficiency, the location and extent of the <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span>, and the patient’s
                            clinical condition. Careful control of replacement therapy is especially
                            important in cases of major surgery or life threatening
                            <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">hemorrhages</span>.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_e1d881a1-5f27-405a-a3a6-11ce903961c8"></a><a name="section-8.1"></a><p></p>
<h2>Reconstitution: Use Aseptic Technique</h2>
<dl>
<dt>1.</dt>
<dd>Bring HEMOFIL M (dry concentrate) and
                                        Sterile Water for Injection, USP, (diluent) to room
                                        temperature.</dd>
<dt>2.</dt>
<dd>Remove caps from concentrate and
                                        diluent bottles to expose central portion of rubber
                                        stoppers.</dd>
<dt>3.</dt>
<dd>Cleanse stoppers with germicidal
                                        solution.</dd>
<dt>4.</dt>
<dd>Remove protective covering from one
                                        end of double-ended needle and insert exposed needle through
                                        diluent stopper.</dd>
<dt>5.</dt>
<dd>Remove protective covering from other
                                        end of double-ended needle. Invert diluent bottle over
                                        upright HEMOFIL M bottle, then rapidly insert free end of
                                        the needle through the HEMOFIL M bottle stopper at its
                                        center. The vacuum in the HEMOFIL M bottle will draw in the
                                        diluent.</dd>
<dt>6.</dt>
<dd>Disconnect the two bottles by
                                        removing needle from diluent bottle stopper, then remove
                                        needle from HEMOFIL M bottle. Swirl gently until all
                                        material is dissolved. Be sure that HEMOFIL M is completely
                                        dissolved; otherwise active material will be removed by the
                                        filter.</dd>
</dl>
<p class="First">Note: Do not refrigerate after
                                    reconstitution.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_66f53112-7077-4fb5-93f6-3de4d606f06e"></a><a name="section-8.2"></a><p></p>
<h2>Administration: Use Aseptic Technique</h2>
<dl>
<dt>•</dt>
<dd>Intravenous administration
                                        only.</dd>
<dt>•</dt>
<dd>Administer at room temperature not
                                        more than 3 hours after reconstitution.</dd>
<dt>•</dt>
<dd>Record the name and batch number of
                                        the product in order to maintain a link between the patient
                                        and the batch of the product.</dd>
</dl>
<p class="First"><span class="Bold">Intravenous Syringe
                                        Injection</span></p>
<dl>
<dt>•</dt>
<dd>Visually inspect parenteral product
                                        for particulate matter and discoloration prior to
                                        administration. The solution should be colorless in
                                        appearance. Do not administer if particulate matter or
                                        discoloration is found.</dd>
<dt>•</dt>
<dd>Plastic syringes are recommended for
                                        use with this product. The ground glass surface of all-glass
                                        syringes tend to stick with solutions of this type.</dd>
</dl>
<p>1. Attach filter needle to a disposable syringe
                                    and draw back plunger to admit air into
                                    syringe.</p>
<p>2. Insert needle into
                                    reconstituted HEMOFIL M.</p>
<p>3. Inject air
                                    into bottle and then withdraw the reconstituted material into
                                    the syringe.</p>
<p>4. Remove and discard the
                                    filter needle from the syringe; attach a suitable needle and
                                    inject intravenously as instructed under <span class="Italics">Rate of
                                    Administration</span>.</p>
<p>5. If a patient
                                    is to receive more than one bottle of HEMOFIL M, the contents of
                                    two bottles may be drawn into the same syringe by drawing up
                                    each bottle through a separate unused filter needle. This
                                    practice lessens the loss of HEMOFIL M. Filter needles are
                                    intended to filter the contents of a single bottle of HEMOFIL M
                                    only.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_1a868f99-752c-4ea6-92ce-5d13e9193bf2"></a><a name="section-8.3"></a><p></p>
<h2>Rate of Administration</h2>
<p class="First">Administer HEMOFIL M at a rate of up to 10 mL per
                                    minute. Infuse HEMOFIL M at a rate of administration that
                                    ensures the comfort of the patient. <span class="Italics">[see Precautions: Increase of Pulse
                                    Rate]</span></p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="ID_6031f050-b00e-4922-ab39-d78175748184"></a><a name="section-9"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">HEMOFIL M is available as single-dose bottles that contain the
                            following nominal potencies:</p>
<table width="100%">
<col width="17%">
<col width="48%">
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Toprule" align="center"><p class="First"><span class="Bold">Nominal
                                                Potency</span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First"><span class="Bold">Kit NDC
                                                Number</span></p></td>
</tr>
<tr>
<td class="Botrule Lrule" align="center"><p class="First"> 250
                                            IU</p></td>
<td class="Botrule Lrule Rrule" align="center"><p class="First">0944-3940-02</p></td>
</tr>
<tr>
<td class="Botrule Lrule" align="center"><p class="First"> 500
                                            IU</p></td>
<td class="Botrule Lrule Rrule" align="center"><p class="First">0944-3942-02</p></td>
</tr>
<tr>
<td class="Botrule Lrule" align="center"><p class="First"> 1000
                                            IU</p></td>
<td class="Botrule Lrule Rrule" align="center"><p class="First">0944-3944-02</p></td>
</tr>
<tr class="Last">
<td class="Botrule Lrule" align="center"><p class="First"> 1700
                                            IU</p></td>
<td class="Botrule Lrule Rrule" align="center"><p class="First">0944-3946-02</p></td>
</tr>
</tbody>
</table>
<p>Each bottle is labeled with the potency in International
                            Units, and is packaged together with 10 mL of Sterile Water for
                            Injection, USP, a double-ended needle, and a filter
                            needle.</p>
<p>Not made with natural rubber
                            latex.</p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="ID_665305d9-1428-4d76-ada7-34d6176a8cb2"></a><a name="section-10"></a><p></p>
<h1>STORAGE</h1>
<p class="First">HEMOFIL M can be stored at 2°C to 8°C (36°F to 46°F) or at room
                            temperature, not to exceed 30°C (86°F), until expiration date noted on
                            the package.</p>
<p>Do not
                                freeze.</p>
<p><span class="Bold">Information
                                for Patients</span></p>
<dl>
<dt>•</dt>
<dd>Advise patients to report any adverse
                                reactions or problems following HEMOFIL M administration to their
                                physician or healthcare provider.</dd>
<dt>•</dt>
<dd>Advise pregnant women or immune compromised
                                individuals of the effects of Parvovirus B19. Symptoms include
                                <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, <span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">chills</span>, <span class="product-label-link" type="condition" conceptid="4170297" conceptname="Sniffles">runny nose</span> followed about two weeks later
                                by a <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, and <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">joint pain</span>. </dd>
<dt>•</dt>
<dd>Inform patients of the signs and symptoms of
                                <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span> A, which include several days to weeks of poor appetite,
                                <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">tiredness</span>, and low-grade <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> followed by <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, and
                                <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> in the belly. Dark urine and a yellowed complexion are also
                                common symptoms. Encourage patients to consult their physician if
                                such symptoms appear.</dd>
<dt>•</dt>
<dd>Inform patients of the early signs of
                                <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reactions</span> including <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">hives</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">generalized urticaria</span>,
                                facial <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, tightness of the chest, <span class="product-label-link" type="condition" conceptid="314754" conceptname="Wheezing">wheezing</span>,
                                <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, and <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span>. Advise patients to
                                discontinue use of the product and contact their physician if these
                                symptoms occur.</dd>
</dl>
</div>
<div class="Section" data-sectionCode="34093-5">
<a name="ID_b9fa341d-02b2-48d7-9246-99b6e073772c"></a><a name="section-11"></a><p></p>
<h1>REFERENCES</h1>
<dl>
<dt>1.</dt>
<dd>Horowitz B, Wiebe ME, Lippin A, <span class="Italics">et al:</span> Inactivation of viruses in
                                labile blood derivatives: 1. Disruption of lipid enveloped viruses
                                by tri(n-butyl)phosphate detergent combinations. <span class="Bold">Transfusion 25</span>:516-522, 1985</dd>
<dt>2.</dt>
<dd>Abildgaard CF, Simone JV, Corrigan JJ,
                                    <span class="Italics">et al</span>: Treatment of
                                <span class="product-label-link" type="condition" conceptid="4236898" conceptname="Hemophilia">hemophilia</span> with glycine-precipitated Factor VIII. <span class="Bold">New Eng J Med 275</span>:471-475, 1966. </dd>
<dt>3.</dt>
<dd>Addiego, Jr. JE, Gomperts E, Liu S. <span class="Italics">et al</span>: Treatment of <span class="product-label-link" type="condition" conceptid="434007" conceptname="Hereditary factor VIII deficiency disease">hemophilia A</span>
                                with a highly purified Factor VIII concentrate prepared by
                                Anti-FVIIIc immunoaffinity chromatography. <span class="Bold"><span class="product-label-link" type="condition" conceptid="4130722" conceptname="Thrombosis">Thrombosis</span> and Haemostasis 67</span>:19-27, 1992. </dd>
</dl>
<p class="First">To enroll in the confidential, industry-wide Patient
                            Notification System, call 1-888-UPDATE U
                            (1-888-873-2838)</p>
<p>Baxter and Hemofil are trademarks
                            of Baxter International Inc.</p>
<p>and are registered in
                            the U.S. Patent and Trademark
                                office.<br></p>
<p><span class="Bold">Baxter
                                Healthcare Corporation</span></p>
<p>Westlake
                            Village, CA 91362 USA</p>
<p>U.S. License No.
                            140</p>
<p>Revised Feb 2014</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_fef2557b-0071-4e2b-a684-7608ca8051bc"></a><a name="section-12"></a><p></p>
<h1>Principle Display Panel</h1>
<div class="Figure">
<a name="id1070"></a><img alt="Hemofil M NF Unit Carton 250 IU" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b8953ff7-3bba-4a0b-a486-f26fb81f05d9&amp;name=image-01.jpg"><p class="MultiMediaCaption">Hemofil M NF Unit Carton 250 IU </p>
</div>
<p class="First">Hemofil M NF Unit Carton 250 IU
                            </p>
<p>10 mL size, dried<br>NDC
                            0944-3940-02</p>
<p><span class="Bold">Antihemophilic Factor
                                (Human)</span></p>
<p><span class="Bold">Method M, Monoclonal
                                Purified</span></p>
<p><span class="Bold">HEMOFIL
                                M</span></p>
<p>Nanofiltered</p>
<p><span class="Bold">FVIII</span></p>
<p><span class="Bold">Intravenous administration
                            only.</span></p>
<p>Administer within 3 hours after
                            reconstitution. </p>
<p>Dosage and Administration: See
                            full prescribing information.</p>
<p>Warning: This
                            product is prepared from large pools of human plasma. Human blood and
                            its components may transit infectious agents. The patient and the
                            physician should discuss the risks and benefits of this
                            product.</p>
<p>Contains no
                                preservative.</p>
<p><span class="Bold">Rx
                                Only</span></p>
<p><span class="Bold">Baxter Healthcare
                            Corporation</span></p>
<p>Westlake Village, CA 91362
                            USA</p>
<p>U.S. License No.
                            140</p>
<div class="Figure">
<a name="id1099"></a><img alt="Hemofil M NF Vial Label 250 IU " src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b8953ff7-3bba-4a0b-a486-f26fb81f05d9&amp;name=image-02.jpg"><p class="MultiMediaCaption">Hemofil M NF Vial Label 250 IU </p>
</div>
<p>Hemofil M NF Vial Label 250 IU
                            </p>
<p>10 mL size, dried</p>
<p>NDC
                            0944-3941-01</p>
<p><span class="Bold">Antihemophilic Factor
                                (Human)</span></p>
<p><span class="Bold">Method M, Monoclonal
                                Purified</span></p>
<p><span class="Bold">HEMOFIL
                                M</span></p>
<p>Nanofiltered</p>
<p><span class="Bold">FVIII</span></p>
<p><span class="Bold">Intravenous administration
                            only</span></p>
<p>Store at 2°- 8°C (38°- 46°F) or
                            room temperature, not to exceed 30°C (86°F) until the expiration date
                            noted on the package. </p>
<p>Dosage and Administration:
                            see package insert. </p>
<p>Contains no
                            preservative.</p>
<p><span class="Bold">Rx
                                Only</span></p>
<p><span class="Bold">Baxter Healthcare
                            Corporation</span></p>
<p>Westlake Village, CA 91362
                            USA</p>
<p>U.S. License No.
                            140</p>
<div class="Figure">
<a name="id1128"></a><img alt="Hemofil M 500 IU unit carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b8953ff7-3bba-4a0b-a486-f26fb81f05d9&amp;name=image-03.jpg"><p class="MultiMediaCaption">Hemofil M Unit Carton 500 IU </p>
</div>
<p>Hemofil M Unit Carton 500 IU
                            </p>
<p>10 mL size, dried</p>
<p>NDC
                            0944-3942-02</p>
<p><span class="Bold">Antihemophilic Factor
                                (Human)</span></p>
<p><span class="Bold">Method M, Monoclonal
                                Purified</span></p>
<p><span class="Bold">HEMOFIL
                                M</span></p>
<p>Nanofiltered</p>
<p><span class="Bold">FVIII</span></p>
<p><span class="Bold">Intravenous administration
                            only.</span></p>
<p>Administer within 3 hours after
                            reconstitution. </p>
<p>Dosage and Administration: See
                            full prescribing information.</p>
<p>Warning: This
                            product is prepared from large pools of human plasma. Human blood and
                            its components may transit infectious agents. The patient and the
                            physician should discuss the risks and benefits of this
                            product.</p>
<p>Contains no
                                preservative.</p>
<p><span class="Bold">Rx
                                Only</span></p>
<p><span class="Bold">Baxter Healthcare
                            Corporation</span></p>
<p>Westlake Village, CA 91362
                            USA</p>
<p>U.S. License No.
                            140</p>
<div class="Figure">
<a name="id1155"></a><img alt="Hemofil M NF Vial Label 500 IU " src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b8953ff7-3bba-4a0b-a486-f26fb81f05d9&amp;name=image-04.jpg"><p class="MultiMediaCaption">Hemofil M Vial Label 500 IU </p>
</div>
<p>Hemofil M Vial Label 500 IU
                            </p>
<p>10 mL size, dried</p>
<p>NDC
                            0944-3943-01</p>
<p><span class="Bold">Antihemophilic Factor
                                (Human)</span></p>
<p><span class="Bold">Method M, Monoclonal
                                Purified</span></p>
<p><span class="Bold">HEMOFIL
                                M</span></p>
<p>Nanofiltered</p>
<p><span class="Bold">FVIII</span></p>
<p><span class="Bold">Intravenous administration
                            only</span></p>
<p>Store at 2°- 8°C (38°- 46°F) or
                            room temperature, not to exceed 30°C (86°F) until the expiration date
                            noted on the package. </p>
<p>Dosage and Administration:
                            see package insert. </p>
<p>Contains no
                            preservative.</p>
<p><span class="Bold">Rx
                                Only</span></p>
<p><span class="Bold">Baxter Healthcare
                            Corporation</span></p>
<p>Westlake Village, CA 91362
                            USA</p>
<p>U.S. License No.
                            140</p>
<div class="Figure">
<a name="id1187"></a><img alt=" Hemofil M NF Unit Carton 1000 IU" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b8953ff7-3bba-4a0b-a486-f26fb81f05d9&amp;name=image-05.jpg"><p class="MultiMediaCaption">Hemofil M 1000 IU Vial Label </p>
</div>
<p>Hemofil M 1000 IU Vial Label
                            </p>
<p>10 mL size, dried</p>
<p>NDC
                            0944-3944-02</p>
<p><span class="Bold">Antihemophilic Factor
                                (Human)</span></p>
<p><span class="Bold">Method M, Monoclonal
                                Purified</span></p>
<p><span class="Bold">HEMOFIL
                                M</span></p>
<p>Nanofiltered</p>
<p><span class="Bold">FVIII</span></p>
<p><span class="Bold">Intravenous administration
                            only.</span></p>
<p>Administer within 3 hours after
                            reconstitution. </p>
<p>Dosage and Administration: See
                            full prescribing information.</p>
<p>Warning: This
                            product is prepared from large pools of human plasma. Human blood and
                            its components may transit infectious agents. The patient and the
                            physician should discuss the risks and benefits of this
                            product.</p>
<p>Contains no
                                preservative.</p>
<p><span class="Bold">Rx
                                Only</span></p>
<p><span class="Bold">Baxter Healthcare
                            Corporation</span></p>
<p>Westlake Village, CA 91362
                            USA</p>
<p>U.S. License No.
                            140</p>
<div class="Figure">
<a name="id1220"></a><img alt="Hemofil M NF Vial Label 1000 IU " src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b8953ff7-3bba-4a0b-a486-f26fb81f05d9&amp;name=image-06.jpg"><p class="MultiMediaCaption">Hemofil M Vial Label 1000 IU</p>
</div>
<p>10 mL size, dried</p>
<p>NDC
                            0944-3945-01</p>
<p><span class="Bold">Antihemophilic Factor
                                (Human)</span></p>
<p><span class="Bold">Method M, Monoclonal
                                Purified</span></p>
<p><span class="Bold">HEMOFIL
                                M</span></p>
<p>Nanofiltered</p>
<p><span class="Bold">FVIII</span></p>
<p><span class="Bold">Intravenous administration
                            only</span></p>
<p>Store at 2°- 8°C (38°- 46°F) or
                            room temperature, not to exceed 30°C (86°F) until the expiration date
                            noted on the package. </p>
<p>Dosage and Administration:
                            see package insert. </p>
<p>Contains no
                            preservative.</p>
<p><span class="Bold">Rx
                                Only</span></p>
<p><span class="Bold">Baxter Healthcare
                            Corporation</span></p>
<p>Westlake Village, CA 91362
                            USA</p>
<p>U.S. License No.
                            140</p>
<div class="Figure">
<a name="id1246"></a><img alt="Hemofil M NF Unit Carton 1700 IU" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b8953ff7-3bba-4a0b-a486-f26fb81f05d9&amp;name=image-07.jpg"><p class="MultiMediaCaption">Hemofil M Unit Carton 1700 IU </p>
</div>
<p>Hemofil M Unit Carton 1700 IU
                            </p>
<p>10 mL size, dried</p>
<p>NDC
                            0944-3946-02</p>
<p><span class="Bold">Antihemophilic Factor
                                (Human)</span></p>
<p><span class="Bold">Method M, Monoclonal
                                Purified</span></p>
<p><span class="Bold">HEMOFIL
                                M</span></p>
<p>Nanofiltered</p>
<p><span class="Bold">FVIII</span></p>
<p><span class="Bold">Intravenous administration only.
                            </span></p>
<p>Administer within 3 hours after
                            reconstitution. </p>
<p>Dosage and Administration: See
                            full prescribing information.</p>
<p>Warning: This
                            product is prepared from large pools of human plasma. Human blood and
                            its components may transit infectious agents. The patient and the
                            physician should discuss the risks and benefits of this
                            product.</p>
<p>Contains no
                                preservative.</p>
<p><span class="Bold">Rx
                                Only</span></p>
<p><span class="Bold">Baxter Healthcare
                            Corporation</span></p>
<p>Westlake Village, CA 91362
                            USA</p>
<p>U.S. License No.
                            140</p>
<div class="Figure">
<a name="id1274"></a><img alt="Hemofil M NF Vial Label 1700 IU" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b8953ff7-3bba-4a0b-a486-f26fb81f05d9&amp;name=image-08.jpg"><p class="MultiMediaCaption">Hemofil M NF Vial Label 1700 IU</p>
</div>
<p>Hemofil M NF Vial Label 1700
                            IU</p>
<p>10 mL size, dried</p>
<p>NDC
                            0944-3947-01</p>
<p><span class="Bold">Antihemophilic Factor
                                (Human)</span></p>
<p><span class="Bold">Method M, Monoclonal
                                Purified</span></p>
<p><span class="Bold">HEMOFIL
                                M</span></p>
<p>Nanofiltered</p>
<p><span class="Bold">FVIII</span></p>
<p><span class="Bold">Intravenous administration
                            only</span></p>
<p>Store at 2°- 8°C (38°- 46°F) or
                            room temperature, not to exceed 30°C (86°F) until the expiration date
                            noted on the package. </p>
<p>Dosage and Administration:
                            see package insert. </p>
<p>Contains no
                            preservative.</p>
<p><span class="Bold">Rx
                                Only</span></p>
<p><span class="Bold">Baxter Healthcare
                            Corporation</span></p>
<p>Westlake Village, CA 91362
                            USA</p>
<p>U.S. License No.
                            140</p>
<div class="Figure">
<a name="id1302"></a><img alt="Sterile Water vial label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b8953ff7-3bba-4a0b-a486-f26fb81f05d9&amp;name=image-09.jpg"><p class="MultiMediaCaption">Sterile Water Vial Label </p>
</div>
<p>Sterile Water Vial Label
                            </p>
<p>NDC
                            0338-0764-61</p>
<p>Nonpyrogenic</p>
<p>Single-Dose
                            Container</p>
<p>10 mL</p>
<p><span class="Bold">Sterile Water for Injection, USP
                            </span></p>
<p><span class="Bold">for
                                reconstitution of accompanying
                            product</span></p>
<p>Do not use unless clear. No
                            antimicrobial agent or other </p>
<p>substance has been
                            added. Do not use for intravascular </p>
<p>injection
                            without making approximately isotonic by </p>
<p>addition
                            of suitable solute. Discard unused portion. </p>
<p>Rx
                            Only.</p>
<p>This Product Contains Dry Natural
                            Rubber.</p>
<p>Manufactured by
                                </p>
<p><span class="Bold">Baxter Healthcare
                                Corporation</span></p>
<p>Deerfield, IL 60015
                            USA</p>
<p>Imported by</p>
<p>Baxter
                            Corporation<br>Toronto, Ontario </p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>HEMOFIL M 		
					</strong><br><span class="contentTableReg">antihemophilic factor human kit</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">PLASMA DERIVATIVE</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0944-3940</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0944-3940-02</td>
<td class="formItem">1  in 1 CARTON; Combination Product Type = C102842</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Quantity of Parts</td></tr>
<tr>
<th scope="col" width="5" class="formTitle">Part #</th>
<th scope="col" class="formTitle">Package Quantity</th>
<th scope="col" class="formTitle">Total Product Quantity</th>
</tr>
<tr class="formTableRowAlt">
<td width="5" class="formItem"><strong>Part 1</strong></td>
<td class="formItem">1 BOTTLE </td>
<td class="formItem">10 mL</td>
</tr>
<tr class="formTableRow">
<td width="5" class="formItem"><strong>Part 2</strong></td>
<td class="formItem">1 BOTTLE </td>
<td class="formItem">10 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 1 of 2</td></tr>
<tr><td class="contentTableTitle">
<strong>HEMOFIL M 		
					</strong><br><span class="contentTableReg">antihemophilic factor human powder, for solution</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0944-3941</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ANTIHEMOPHILIC FACTOR HUMAN</strong> (ANTIHEMOPHILIC FACTOR HUMAN) </td>
<td class="formItem">ANTIHEMOPHILIC FACTOR HUMAN</td>
<td class="formItem">250 [iU]  in 10 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ALBUMIN HUMAN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYETHYLENE GLYCOL 3350</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>HISTIDINE</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0944-3941-01</td>
<td class="formItem">10 mL in 1 BOTTLE; Combination Product Type = C102842</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA101448</td>
<td class="formItem">02/23/1988</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 2 of 2</td></tr>
<tr><td class="contentTableTitle">
<strong>STERILE WATER 		
					</strong><br><span class="contentTableReg">water liquid</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0338-0764</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">10 mL  in 10 mL</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0338-0764-61</td>
<td class="formItem">10 mL in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA101448</td>
<td class="formItem">02/23/1988</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA101448</td>
<td class="formItem">02/23/1988</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>HEMOFIL M 		
					</strong><br><span class="contentTableReg">antihemophilic factor human kit</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">PLASMA DERIVATIVE</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0944-3942</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0944-3942-02</td>
<td class="formItem">1  in 1 CARTON; Combination Product Type = C102842</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Quantity of Parts</td></tr>
<tr>
<th scope="col" width="5" class="formTitle">Part #</th>
<th scope="col" class="formTitle">Package Quantity</th>
<th scope="col" class="formTitle">Total Product Quantity</th>
</tr>
<tr class="formTableRowAlt">
<td width="5" class="formItem"><strong>Part 1</strong></td>
<td class="formItem">1 BOTTLE </td>
<td class="formItem">10 mL</td>
</tr>
<tr class="formTableRow">
<td width="5" class="formItem"><strong>Part 2</strong></td>
<td class="formItem">1 BOTTLE </td>
<td class="formItem">10 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 1 of 2</td></tr>
<tr><td class="contentTableTitle">
<strong>HEMOFIL M 		
					</strong><br><span class="contentTableReg">antihemophilic factor human powder, for solution</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0944-3943</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ANTIHEMOPHILIC FACTOR HUMAN</strong> (ANTIHEMOPHILIC FACTOR HUMAN) </td>
<td class="formItem">ANTIHEMOPHILIC FACTOR HUMAN</td>
<td class="formItem">500 [iU]  in 10 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ALBUMIN HUMAN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYETHYLENE GLYCOL 3350</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>HISTIDINE</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0944-3943-01</td>
<td class="formItem">10 mL in 1 BOTTLE; Combination Product Type = C102842</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA101448</td>
<td class="formItem">02/23/1988</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 2 of 2</td></tr>
<tr><td class="contentTableTitle">
<strong>STERILE WATER 		
					</strong><br><span class="contentTableReg">water liquid</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0338-0764</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">10 mL  in 10 mL</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0338-0764-61</td>
<td class="formItem">10 mL in 1 BOTTLE; Combination Product Type = C102842</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA101448</td>
<td class="formItem">02/23/1988</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA101448</td>
<td class="formItem">02/23/1988</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>HEMOFIL M 		
					</strong><br><span class="contentTableReg">antihemophilic factor human kit</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">PLASMA DERIVATIVE</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0944-3944</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0944-3944-02</td>
<td class="formItem">1  in 1 CARTON; Combination Product Type = C102842</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Quantity of Parts</td></tr>
<tr>
<th scope="col" width="5" class="formTitle">Part #</th>
<th scope="col" class="formTitle">Package Quantity</th>
<th scope="col" class="formTitle">Total Product Quantity</th>
</tr>
<tr class="formTableRowAlt">
<td width="5" class="formItem"><strong>Part 1</strong></td>
<td class="formItem">1 BOTTLE </td>
<td class="formItem">10 mL</td>
</tr>
<tr class="formTableRow">
<td width="5" class="formItem"><strong>Part 2</strong></td>
<td class="formItem">1 BOTTLE </td>
<td class="formItem">10 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 1 of 2</td></tr>
<tr><td class="contentTableTitle">
<strong>HEMOFIL M 		
					</strong><br><span class="contentTableReg">antihemophilic factor human powder, for solution</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0944-3945</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ANTIHEMOPHILIC FACTOR HUMAN</strong> (ANTIHEMOPHILIC FACTOR HUMAN) </td>
<td class="formItem">ANTIHEMOPHILIC FACTOR HUMAN</td>
<td class="formItem">1000 [iU]  in 10 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ALBUMIN HUMAN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYETHYLENE GLYCOL 3350</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>HISTIDINE</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0944-3945-01</td>
<td class="formItem">10 mL in 1 BOTTLE; Combination Product Type = C102842</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA101448</td>
<td class="formItem">02/23/1988</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 2 of 2</td></tr>
<tr><td class="contentTableTitle">
<strong>STERILE WATER 		
					</strong><br><span class="contentTableReg">water liquid</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0338-0764</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">10 mL  in 10 mL</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0338-0764-61</td>
<td class="formItem">10 mL in 1 BOTTLE; Combination Product Type = C102842</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA101448</td>
<td class="formItem">02/23/1988</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA101448</td>
<td class="formItem">02/23/1988</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>HEMOFIL M 		
					</strong><br><span class="contentTableReg">antihemophilic factor human kit</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">PLASMA DERIVATIVE</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0944-3946</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0944-3946-02</td>
<td class="formItem">1  in 1 CARTON; Combination Product Type = C102842</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Quantity of Parts</td></tr>
<tr>
<th scope="col" width="5" class="formTitle">Part #</th>
<th scope="col" class="formTitle">Package Quantity</th>
<th scope="col" class="formTitle">Total Product Quantity</th>
</tr>
<tr class="formTableRowAlt">
<td width="5" class="formItem"><strong>Part 1</strong></td>
<td class="formItem">1 BOTTLE </td>
<td class="formItem">10 mL</td>
</tr>
<tr class="formTableRow">
<td width="5" class="formItem"><strong>Part 2</strong></td>
<td class="formItem">1 BOTTLE </td>
<td class="formItem">10 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 1 of 2</td></tr>
<tr><td class="contentTableTitle">
<strong>HEMOFIL M 		
					</strong><br><span class="contentTableReg">antihemophilic factor human powder, for solution</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0944-3947</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ANTIHEMOPHILIC FACTOR HUMAN</strong> (ANTIHEMOPHILIC FACTOR HUMAN) </td>
<td class="formItem">ANTIHEMOPHILIC FACTOR HUMAN</td>
<td class="formItem">1700 [iU]  in 10 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ALBUMIN HUMAN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYETHYLENE GLYCOL 3350</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>HISTIDINE</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0944-3947-01</td>
<td class="formItem">10 mL in 1 BOTTLE; Combination Product Type = C102842</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA101448</td>
<td class="formItem">02/23/1988</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 2 of 2</td></tr>
<tr><td class="contentTableTitle">
<strong>STERILE WATER 		
					</strong><br><span class="contentTableReg">water liquid</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0338-0764</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">10 mL  in 10 mL</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0338-0764-61</td>
<td class="formItem">10 mL in 1 BOTTLE; Combination Product Type = C102842</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA101448</td>
<td class="formItem">02/23/1988</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA101448</td>
<td class="formItem">02/23/1988</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Baxter Healthcare Corporation
							(039121363)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BAXTER HEALTHCARE CORPORATION</td>
<td class="formItem"></td>
<td class="formItem">085206634</td>
<td class="formItem">MANUFACTURE</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Baxter Healthcare Corporation</td>
<td class="formItem"></td>
<td class="formItem">001728059</td>
<td class="formItem">MANUFACTURE</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 4/2012<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>1212b06c-0455-42ed-98fa-1ffaf9730b89</div>
<div>Set id: b8953ff7-3bba-4a0b-a486-f26fb81f05d9</div>
<div>Version: 9</div>
<div>Effective Time: 20120420</div>
</div>
</div> <div class="DistributorName">Baxter Healthcare Corporation</div></p>
</body></html>
